参考文献: https://clinicaltrials.gov/study/NCT03036462 https://doi.org/10.1002/ejhf.3574 如发现文内有误请联系我们 POCKETIN 将挑选重点研究,就已发布结果邀请专家陆续解读 POCKETIN接受投稿,我们将为撰稿作者提供该研究的过往...
The impact of intravenous ferric carboxymaltose on renal function: An analysis of the FAIR-HF study. Eur. J. Heart Fail. 2015; 17 :329–339. doi: 10.1002/ejhf.229. [ Cross Ref ]Ponikowski, P, Filippatos, G, Colet, JC (2015) The impact of intravenous ferric carboxymaltose on renal ...
The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study 来自 EBSCO 喜欢 0 阅读量: 80 作者:EM Van Craenenbroeck,VM Conraads,N Greenlaw,G Gaudesius,C Mori,P Ponikowski,SD Anker ...
Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR‐HF substudyIronCongestionPlasma volumeOedemaAimsIron deficiency worsens symptoms, quality of life, and exercise capacity in chronic heart failure (CHF) and might do so by promoting fluid retention. We ...
The process of perceiving others is rarely translated(to ourselves or others) into cold,objective terms."She was 5 feet 8 inches tall, had fair hair, and wore a colored skirt." More often, we try to get inside the other person to pinpoint his or her attitudes, emotions, mo...
The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study. Circulation 2010;122:A17341.Ponikowski P, Macdougall I, Anker SD. The impact of intra- venous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study (poster). In: 43rd...
The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study. Eur J Heart Fail. 2015;17:329-339. doi: 10.1002/ejhf.229.The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study/ Ponikowski P., Filippatos G....
The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study. Eur J Heart Fail 2013;15: 756 -762.Van Craenenbroeck, E.M.; Conraads, V.M.; Greenlaw, N.; Gaudesius, G.; Mori, C.; Ponikowski, P.; Anker, S.D. The effect ...
Patients with heart failure randomized to high-dose losartan treatment (150 mg) in the HEAAL study had a reduced risk of death or heart failure hospitalization compared with patients in the low-dose (50 mg) group. In FAIR-HF, patients with heart failure and concomitant iron deficiency but ...
Patients with heart failure randomized to high-dose losartan treatment (150 mg) in the HEAAL study had a reduced risk of death or heart failure hospitalization compared with patients in the low-dose (50 mg) group. In FAIR-HF, patients with heart failure and concomitant iron deficiency but ...